Integrated Quantitative Investments LLC Makes New Investment in Tenet Healthcare Corporation $THC

Integrated Quantitative Investments LLC purchased a new stake in Tenet Healthcare Corporation (NYSE:THC) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 2,926 shares of the company’s stock, valued at approximately $594,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. William B. Walkup & Associates Inc. acquired a new position in Tenet Healthcare in the third quarter valued at about $32,000. Canada Pension Plan Investment Board acquired a new position in shares of Tenet Healthcare in the 2nd quarter worth approximately $35,000. Westside Investment Management Inc. boosted its position in shares of Tenet Healthcare by 100.0% during the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after purchasing an additional 96 shares during the period. Trust Co. of Vermont purchased a new stake in Tenet Healthcare in the third quarter valued at approximately $41,000. Finally, True Wealth Design LLC lifted its stake in Tenet Healthcare by 238.2% during the second quarter. True Wealth Design LLC now owns 257 shares of the company’s stock worth $45,000 after purchasing an additional 181 shares in the last quarter. 95.44% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, EVP Thomas W. Arnst sold 24,000 shares of the company’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $234.04, for a total value of $5,616,960.00. Following the completion of the sale, the executive vice president directly owned 8,012 shares of the company’s stock, valued at $1,875,128.48. This represents a 74.97% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider R. Scott Ramsey sold 8,017 shares of Tenet Healthcare stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total value of $1,865,555.90. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 34,195 shares of company stock valued at $7,912,606. Insiders own 0.81% of the company’s stock.

Tenet Healthcare Stock Performance

Shares of Tenet Healthcare stock opened at $240.88 on Friday. The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18. Tenet Healthcare Corporation has a 52 week low of $109.82 and a 52 week high of $247.21. The firm’s 50 day moving average is $209.41 and its two-hundred day moving average is $201.66. The firm has a market capitalization of $20.95 billion, a P/E ratio of 15.55, a P/E/G ratio of 1.21 and a beta of 1.39.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The business had revenue of $5.53 billion during the quarter, compared to analysts’ expectations of $5.47 billion. During the same quarter in the prior year, the business posted $3.44 EPS. The company’s revenue for the quarter was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Research analysts forecast that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on THC shares. Leerink Partners boosted their price objective on Tenet Healthcare from $255.00 to $264.00 and gave the company an “outperform” rating in a report on Friday, February 20th. Weiss Ratings raised Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. Jefferies Financial Group raised their price objective on shares of Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a research note on Thursday, February 12th. Morgan Stanley reaffirmed an “overweight” rating and set a $260.00 target price on shares of Tenet Healthcare in a research note on Thursday, February 12th. Finally, Barclays raised their price target on shares of Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a research report on Friday, February 13th. One analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $247.67.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.